David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents
News & Insights
Charlotte Duly joins Charles Russell Speechlys as Head of Brand Protection
Brand protection specialist Charlotte Duly joins the firm's Intellectual Property Group
The menopause - can business afford to ignore the potential productivity loss of 14 million days a year?
It is clearly in the interests of business to retain the talent and experience of those working women who are dealing with the menopause.
The value of Simone Biles – an update on athlete endorsements, the Olympics and Rule 40
the USOPC released updated guidance for its athletes regarding personal endorsements and marketing during the Tokyo 2020 games.